Brenig Therapeutics is based in Amsterdam, Netherlands. It has raised $65M in total funding. Latest round: Series A.
Brenig Therapeutics is based in Amsterdam, Netherlands. Brenig Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Brenig Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include New Enterprise Associates, OrbiMed, Torrey Pines Investments, BioGeneration Ventures. 4 distinct backers are named across the disclosed rounds.
Round data for Brenig Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Amsterdam and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026